Safety of Gadolinium-Based Contrast Material in Sickle Cell Disease

Journal of Magnetic Resonance Imaging- United States

doi 10.1002/jmri.22666

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Safety of Gadolinium-Based Contrast Agents in Patients With Stage 4 and 5 Chronic Kidney Disease: A Radiologist’s Perspective

Kidney360
2020English

Brain Gadolinium Deposition After Administration of Gadolinium-Based Contrast Agents

Japanese Journal of Radiology
Nuclear MedicineRadiologyImaging
2015English

How Should Nephrologists Approach Gadolinium-Based Contrast Imaging in Patients With Kidney Disease?

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

The Sickle Cell Disease Implementation Consortium: Translating Evidence-Based Guidelines Into Practice for Sickle Cell Disease

American Journal of Hematology
Hematology
2018English

Sickle Cell Disease

Revista Brasileira de Hematologia e Hemoterapia
2011English

Sickle Cell Disease

Journal of Medical Genetics
Genetics
1988English

Transfusion and Alloimmunization in Sickle Cell Disease. The Cooperative Study of Sickle Cell Disease

Blood
BiochemistryImmunologyCell BiologyHematology
1990English

Sickle Cell Disease in Childhood

Pediatric Clinics of North America
Child HealthPediatricsPerinatology
2013English

Gadolinium-Based Contrast Agents for Magnetic Resonance Cancerimaging

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
MedicineBioengineeringNanotechnologyBiomedical EngineeringNanoscience
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy